Biotech Values

[DewDiligence]

How desperate is Teva to save the Copaxone franchise? They recently filed for a patent on an injectable fixed-dose combination of Copaxone and Laquinimod:

http://www.fiercebiotech.com/story/teva-retrenches-troubled-ms-blockbuster-hopeful-partner-grabs-43m/2013-03-06

If such a product ever becomes a commercial success, I’ll stop posting on all biotech message boards! (Laquinimod is not yet approved in any major jurisdictions.)

The idea of combining these two drugs is not new (e.g. http://www.businessweek.com/news/2012-10-11/teva-to-test-ms-pill-laquinimod-in-combination-therapy ); however, the idea of an injectable fixed-dose combination is new, as far as I know.